Venture fund & syndicate investing in transformational technologies that elevate
mental health & wellness: psychedelic medicine, neurotechnology, precision psychiatry and digital therapeutics.
Location: United States, California, San Francisco
Employees: 1-10
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | Ambush Cap... | ambush.cap... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 26.01.2024 | Motif Neurotech Raises $18.75M for Implantable Device for Tr... | What You Should Know: – Motif Neurotech, a pioneer in minimally-invasive bioelectronics for mental h... | hitconsult... |
| 12.05.2023 | 11 investors predict a colorful, if difficult, future for ps... | How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on wh... | techcrunch... |
| 16.03.2023 | Meet the top 14 VCs who've bet the most cash on turning psyc... | Sean McLintock, Sonia Weiss Pick, Michael Sobeck, and Nikolay Tretiyakov Neo Kuma Ventures, WPSS.bio... | businessin... |
| 04.05.2022 | Psychedelics startups are on a long journey to consumer mark... | “Like a pressure cooker, COVID blew the lid off what was a simmering mental health crisis for over a... | techcrunch... |
| 08.01.2022 | Venture water, biotech investing and 2021’s carnage | Welcome to The TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the d... | techcrunch... |
| - | PsyMed Ventures’ Greg Kubin on Investing in Psychedelics | Greg Kubin thinks that the hippies had it right all along. “They adopted certain healthy eating prac... | dot.la/psy... |